Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02511678 · ClinicalTrials.gov registry record · NA
Multicenter Study of Cryoablation for Palliation of Painful Bone Metastases
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT02511678 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 73 participants.
The verdict
NCT02511678, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of cryoablation for palliation of painful metastases in participants with metastatic lesions involving bone who have failed, are not candidates for, or are not experiencing adequate pain relief from current pain therapies (for example, radiation, analgesics).
Interventions
- DEVICE Cryoablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2016-02-15 |
| Est. Completion | 2018-03-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02511678
The ClinicalTrials.gov registry entry for NCT02511678 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cryoablation is the first listed.
NCT02511678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02511678 about?
NCT02511678 is a clinical study titled "Multicenter Study of Cryoablation for Palliation of Painful Bone Metastases". This study will evaluate the efficacy of cryoablation for palliation of painful metastases in participants with metastatic lesions involving bone who have failed, are not candidates for, or are not experiencing adequate pain relief from current pain therapies (for example, radiation, analgesics).
What is the current status of trial NCT02511678?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2016-02-15. Estimated completion is 2018-03-12.
What interventions are being tested in trial NCT02511678?
The interventions under investigation include: Cryoablation (DEVICE).
Who is sponsoring clinical trial NCT02511678?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.